Acorah Software Products - Accounts Production 16.1.200 false true 31 August 2023 1 September 2022 false 1 September 2023 31 March 2024 31 March 2024 14179246 Ms Kayleigh Stocker Mr Benjamin O'Brien Mr Ashley Simpson Davies Mr Harry Mongini Mr Paul O'Brien Mr Martin Davies iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14179246 2023-08-31 14179246 2024-03-31 14179246 2023-09-01 2024-03-31 14179246 frs-core:CurrentFinancialInstruments 2024-03-31 14179246 frs-core:PlantMachinery 2024-03-31 14179246 frs-core:PlantMachinery 2023-09-01 2024-03-31 14179246 frs-core:PlantMachinery 2023-08-31 14179246 frs-core:ShareCapital 2024-03-31 14179246 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31 14179246 frs-bus:PrivateLimitedCompanyLtd 2023-09-01 2024-03-31 14179246 frs-bus:FilletedAccounts 2023-09-01 2024-03-31 14179246 frs-bus:SmallEntities 2023-09-01 2024-03-31 14179246 frs-bus:AuditExempt-NoAccountantsReport 2023-09-01 2024-03-31 14179246 frs-bus:SmallCompaniesRegimeForAccounts 2023-09-01 2024-03-31 14179246 frs-bus:Director1 2023-09-01 2024-03-31 14179246 frs-bus:Director2 2023-09-01 2024-03-31 14179246 frs-bus:Director3 2023-09-01 2024-03-31 14179246 frs-bus:Director3 2023-08-31 14179246 frs-bus:Director3 2024-03-31 14179246 frs-bus:Director4 2023-09-01 2024-03-31 14179246 frs-bus:Director5 2023-09-01 2024-03-31 14179246 frs-bus:Director6 2023-09-01 2024-03-31 14179246 frs-countries:EnglandWales 2023-09-01 2024-03-31 14179246 2022-08-31 14179246 2023-08-31 14179246 2022-09-01 2023-08-31 14179246 frs-core:CurrentFinancialInstruments 2023-08-31 14179246 frs-core:ShareCapital 2023-08-31 14179246 frs-core:RetainedEarningsAccumulatedLosses 2023-08-31
Registered number: 14179246
Kanvas Medical Group Ltd
Unaudited Financial Statements
For the Period 1 September 2023 to 31 March 2024
CJM Associates
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 14179246
31 March 2024 31 August 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 16,763 -
16,763 -
CURRENT ASSETS
Stocks 5 - 18,370
Debtors 6 306 1,733
Cash at bank and in hand 57,042 70,650
57,348 90,753
Creditors: Amounts Falling Due Within One Year 7 (37,240 ) (41,669 )
NET CURRENT ASSETS (LIABILITIES) 20,108 49,084
TOTAL ASSETS LESS CURRENT LIABILITIES 36,871 49,084
NET ASSETS 36,871 49,084
CAPITAL AND RESERVES
Called up share capital 8 1,000 1,000
Profit and Loss Account 35,871 48,084
SHAREHOLDERS' FUNDS 36,871 49,084
Page 1
Page 2
For the period ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Harry Mongini
Director
14/02/2025
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Kanvas Medical Group Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14179246 . The registered office is Unit 28-29 Centurion House, Anson Court, Staffordshire Technology Park, Stafford, ST18 0GB.
The presentation currency of the financial statements is Pound Sterling (£)
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. 
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 15% reducing balance
2.4. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
2.5. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the period was: 3 (2023: 3)
3 3
Page 3
Page 4
4. Tangible Assets
Plant & Machinery
£
Cost
As at 1 September 2023 -
Additions 18,370
As at 31 March 2024 18,370
Depreciation
As at 1 September 2023 -
Provided during the period 1,607
As at 31 March 2024 1,607
Net Book Value
As at 31 March 2024 16,763
As at 1 September 2023 -
5. Stocks
31 March 2024 31 August 2023
£ £
Stock - 18,370
6. Debtors
31 March 2024 31 August 2023
£ £
Due within one year
Other debtors 306 1,733
7. Creditors: Amounts Falling Due Within One Year
31 March 2024 31 August 2023
£ £
Other creditors 21,949 18,412
Taxation and social security 15,291 23,257
37,240 41,669
8. Share Capital
31 March 2024 31 August 2023
£ £
Allotted, Called up and fully paid 1,000 1,000
Page 4
Page 5
9. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 September 2023 Amounts advanced Amounts repaid Amounts written off As at 31 March 2024
£ £ £ £ £
Mr Benjamin O'Brien 488 182 - - 306
The above loan is unsecured, interest free and repayable on demand.
Page 5